Overall, in all NSCLC cell lines upregulation of CD86 was more pronounced compared to CD80 and significantly upregulated after treatment with DOC, CARBO, CDDP, DOC + CARBO and DOC + CDDP compared to vehicle. The gene discussed is CD80; the disease is non-small cell lung carcinoma.